国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01099 国药控股

已收盘 12-19 16:08:47

21.500

-0.200

-0.92%

最高21.700	最低21.350	成交量400.30万
今开21.500	昨收21.700	日振幅1.61%
总市值670.94亿	流通市值288.53亿	总股本31.21亿
成交额8,609万	换手率0.30%	流通股本13.42亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01099","market":"HK","secType":"STK","nameCN":"国药控股","latestPrice":21.5,"timestamp":1734595727013,"preClose":21.7,"halted":0,"volume":4002986,"delay":0,"floatShares":1342000000,"shares":3120656191,"eps":3.1160471,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.2,"latestTime":"12-19 16:08:47","open":21.5,"high":21.7,"low":21.35,"amount":86085483,"amplitude":0.016129,"askPrice":21.55,"askSize":24400,"bidPrice":21.5,"bidSize":51600,"shortable":3,"etf":0,"ttmEps":2.978184232080372,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"listingDate":1253635200000,"adjPreClose":21.7,"dividendRate":0.043408,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0.497808,"impliedVol":0.3474,"impliedVolPercentile":0.1984,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SNP.HK"},"requestUrl":"/m/hq/s/01099","defaultTab":"news","newsList":[{"id":"2492214693","title":"国药控股12月19日主力资金流入1476万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2492214693","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492214693?lang=zh_cn&edition=full","pubTime":"2024-12-19 16:15","pubTimestamp":1734596111,"startTime":"0","endTime":"0","summary":"12月19日, 国药控股股价跌0.92%，报收21.50元，成交金额8608万元，换手率0.30%，振幅1.61%，量比0.50。国药控股今日主力资金净流入1476万元，连续3日净流入，上一交易日主力净流入590万元，今日环比增加150.17%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为40.00%，平均涨幅为1.18%。该股近5个交易日下跌0.70%，主力资金累计净流入2221万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入8878万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219162431ab83eec3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219162431ab83eec3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0640798160.USD","BK1197","LU1115378108.SGD","BK1515","01099","BK1500"],"gpt_icon":0},{"id":"2492922116","title":"市值管理政策再迎加码，优质破净央企或成最稳的“压舱石”","url":"https://stock-news.laohu8.com/highlight/detail?id=2492922116","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492922116?lang=zh_cn&edition=full","pubTime":"2024-12-19 13:46","pubTimestamp":1734587203,"startTime":"0","endTime":"0","summary":"金吾财讯 | 回顾2024年的市场主线，在市值管理政策不断地加码下，以央国企为主导的红利概念似乎成为年内最“稳”的概念。政策端方面，17日出台的《意见》对指数成分股、长期破净股提出明确要求，在标的选择方面划出明确界线。在近期的市值管理政策中，分红工具是多数央国企率先使用的市值管理工具，而政策导向有望进一步提升相关公司的股息率，进一步提高其对资产的吸引力。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MzQxNzMxMDUyMTQyMzY4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQxNzMxMDUyMTQyMzY4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949963","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01857","00390","BK1565","01606","01898","02628","LU1504937902.USD","01109","LU1282651121.HKD","LU1770034418.SGD","00857","LU0856984785.SGD","IE00BGHQDM52.EUR","HSCEI","LU0886674414.USD","01883","02666","03143","03877","BK1184","BK1584","159982","SG9999003461.SGD","LU1366334578.USD","BK1550","SG9999012736.USD","HSTECH","LU2328871848.SGD","82388","LU0173614495.USD","LU1481107354.HKD","LU0048597586.USD","BHKLY","02388","YANG","03311","HK0000306701.USD","LU0359201612.USD","LU0405327148.USD","LU0164880469.USD","01099","LU0633140560.USD","LU0348784397.USD","01398","LU1224709979.USD","LU0469268626.HKD","399300","00939","01138"],"gpt_icon":1},{"id":"2492294965","title":"国药控股12月17日获南向资金加仓303.84万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492294965","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492294965?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:30","pubTimestamp":1734485415,"startTime":"0","endTime":"0","summary":"12月17日, 南向资金增持国药控股303.84万股。截止当日收盘，港股通共持有国药控股33274.91万股，占流通股24.79%。国药控股近5个交易日上涨1.42%，港股通累计增持1127.04万股；近20个交易日上涨3.86%，港股通累计增持4965.68万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218093346a1f733d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218093346a1f733d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","BK1197","LU1115378108.SGD","LU0640798160.USD","01099","BK1515"],"gpt_icon":0},{"id":"2491669821","title":"CITIC Securities Company Limited增持国药控股(01099)281.36万股 每股作价约21.25港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491669821","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491669821?lang=zh_cn&edition=full","pubTime":"2024-12-16 18:49","pubTimestamp":1734346194,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，12月11日，CITIC Securities Company Limited增持国药控股(01099)281.36万股，每股作价21.2531港元，总金额约为5979.77万港元。增持后最新持股数目约为1.09亿股，最新持股比例为8.16%。补充资料：权益为中信证券资产管理有限公司代其管理的全部资产管理计划披露持有的国药控股股份有限公司 - H股权益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1115378108.SGD","LU0640798160.USD","BK1197","BK1515","01099","BK1500"],"gpt_icon":0},{"id":"2491658545","title":"喜讯！国药控股副总裁、董事会秘书吴壹建荣获第十九届“金圆桌奖”最具创新力董秘奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2491658545","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491658545?lang=zh_cn&edition=full","pubTime":"2024-12-16 13:29","pubTimestamp":1734326940,"startTime":"0","endTime":"0","summary":"近日，资本市场高度关注的第十九届中国上市公司董事会“金圆桌奖”发布获奖名单，国药控股副总裁、董事会秘书吴壹建荣获第十九届“金圆桌奖”最具创新力董秘奖。据悉，“金圆桌奖”被誉为中国企业公司治理领域的金奖， “金圆桌奖”系列奖项中专门为勤勉尽责、勇于革新、贡献突出的董事会秘书设立了“最具创新力董秘”，旨在表彰以自身创新力和实践力，助推上市公司规范治理、稳健发展的优秀董事会秘书。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-16/doc-inczrrav2721732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1115378108.SGD","BK1197","BK1515","LU0640798160.USD","01099","BK1500"],"gpt_icon":0},{"id":"2491324055","title":"智通港股解盘 | 预期出现差异再度杀跌 首发经济有待催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2491324055","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491324055?lang=zh_cn&edition=full","pubTime":"2024-12-13 20:38","pubTimestamp":1734093527,"startTime":"0","endTime":"0","summary":"昨天市场都预期会议有较大刺激然后冲了一波，但今天市场反馈都不怎么好，A50的下跌直接导致两地均低开低走，港股收盘跌2.09%。中央经济工作会议12月11日至12日在北京举行。会议要求，要实施适度宽松的货币政策。发挥好货币政策工具总量和结构双重功能，适时降准降息，保持流动性充裕，使社会融资规模、货币供应量增长同经济增长、价格总水平预期目标相匹配。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224919.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1103","IE00BYQNZ168.SGD","IE00B12V2V27.USD","HSTECH","BK1179","BK1500","BK1224","IE00BYTNYN87.SGD","LU0640798160.USD","BK1197","01099","01308","BK1504","LU0348766576.USD","BK1096","YANG","LU1115378108.SGD","HSCEI","01478","BK1541","LU0348767384.USD","SG9999011746.SGD","BK1515"],"gpt_icon":1},{"id":"2491345123","title":"港股三大指数午后跌幅扩大 恒指全日跌2.09% 龙湖集团(00960)跌7.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491345123","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491345123?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:18","pubTimestamp":1734077904,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股三大指数午后跌幅扩大，全日低开低走，截至收盘，恒指跌2.09%，恒科指跌2.63%，国企指跌2.36%。公司公布，截至2024年11月30日止一个月，公司及其附属公司实现总合同销售金额约人民币258.0亿元，总合同销售建筑面积约120.3万平方米，分别按年增长6.9%及11.1%。2024年前11月累计合同销售金额约人民币2291.0亿元，总合同销售建筑面积约1,003.1万平方米，分别按年减少19.9%及16.8%。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/NzMyOTI2MTc2NzYxOTM1NTM3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NzMyOTI2MTc2NzYxOTM1NTM3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949631","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1515","02382","01209","LU1115378108.SGD","LU0326950275.SGD","LU0762540952.USD","BK1180","HSI","BK1170","HSImain","LU0029875118.USD","01876","MCHmain","BK1578","SG9999000459.SGD","01099","BK1240","HSTECH","HHImain","BK1197","BK1542","LU0128522157.USD","BK1500","LU0831093199.SGD","02833","LU0630378692.HKD","LU0197773673.USD","LU1831875114.USD","LU0630378429.USD","00316","LU0051755006.USD","00960","LU0640798160.USD","LU0762542818.HKD","LU0456846285.SGD","BK1604","BK1229","YANG","BK1258","513600","HSCEI","MHImain","BK1555","LU0543330483.HKD","BK1504","BK1103","BK1521","SG9999001903.USD"],"gpt_icon":1},{"id":"2491271398","title":"国药控股12月12日获南向资金加仓312.32万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491271398","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491271398?lang=zh_cn&edition=full","pubTime":"2024-12-13 09:30","pubTimestamp":1734053414,"startTime":"0","endTime":"0","summary":"12月12日, 南向资金增持国药控股312.32万股。截止当日收盘，港股通共持有国药控股32799.27万股，占流通股24.44%。国药控股近5个交易日上涨5.12%，港股通累计增持1146.24万股；近20个交易日上涨6.42%，港股通累计增持5771.96万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213093118a1ea8350&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213093118a1ea8350&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01099","LU0640798160.USD","BK1515","BK1500","LU1115378108.SGD","BK1197"],"gpt_icon":0},{"id":"2490397900","title":"国药控股12月9日获南向资金加仓164.44万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490397900","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490397900?lang=zh_cn&edition=full","pubTime":"2024-12-10 09:30","pubTimestamp":1733794216,"startTime":"0","endTime":"0","summary":"12月9日, 南向资金增持国药控股164.44万股。截止当日收盘，港股通共持有国药控股31955.59万股，占流通股23.80%。港股通增持金额前五个股分别为建设银行、比亚迪电子、速腾聚创、中国海洋石油、工商银行。国药控股近5个交易日上涨2.92%，港股通累计增持1264.24万股；近20个交易日上涨2.17%，港股通累计增持5221.20万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210093128ab6b4f5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210093128ab6b4f5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1197","BK1500","01099","LU0640798160.USD","LU1115378108.SGD"],"gpt_icon":0},{"id":"2490104717","title":"国药控股12月09日获主力加仓1362万元 环比增加465.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490104717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490104717?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:16","pubTimestamp":1733732193,"startTime":"0","endTime":"0","summary":"12月09日, 国药控股股价涨2.92%，报收21.15元，成交金额2.02亿元，换手率0.73%，振幅4.38%，量比1.40。国药控股今日主力资金净流入1362万元，连续4日净流入，上一交易日主力净流入241万元，今日环比增加465.15%。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为56.25%，平均涨幅为2.87%。该股近5个交易日上涨2.43%，主力资金累计净流入2184万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.85亿元，其中净流入天数为17日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209161736ab69429a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209161736ab69429a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","LU0640798160.USD","BK1500","BK1197","01099","BK1515"],"gpt_icon":0},{"id":"2489401176","title":"国药控股12月06日主力资金流入241万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2489401176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489401176?lang=zh_cn&edition=full","pubTime":"2024-12-06 16:15","pubTimestamp":1733472939,"startTime":"0","endTime":"0","summary":"12月06日, 国药控股股价涨0.24%，报收20.55元，成交金额1.67亿元，换手率0.61%，振幅1.95%，量比1.09。国药控股今日主力资金净流入241万元，连续3日净流入，上一交易日主力净流入431万元，今日环比减少44.08%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为36.84%，平均涨幅为1.25%。该股近5个交易日上涨0.25%，主力资金累计净流入466万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1.47亿元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206161608a1d8a1bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206161608a1d8a1bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0640798160.USD","BK1197","LU1115378108.SGD","01099","BK1515","BK1500"],"gpt_icon":0},{"id":"2489263954","title":"【券商聚焦】第一上海维持国药控股(01099)买入评级 指老龄化加速背景下药品分销业务发展稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=2489263954","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489263954?lang=zh_cn&edition=full","pubTime":"2024-12-06 10:56","pubTimestamp":1733453809,"startTime":"0","endTime":"0","summary":"金吾财讯 | 第一上海发研指，国药控股 2024年前三季度累计实现收入4424.2亿元，同比减少0.78%。前三季度公司整体毛利率同比下降0.68pts至7.55%。公司Q3收入同比恢复增长1.88%，但主要是由于2023Q3医疗反腐导致的低基数，环比增速仅0.16%。归母净利润15.75亿元，同比减少20.94%，主要由于整体毛利率下降以及应收账款相关信用减值损失，以及23H1子公司收到大额拆迁补偿款所致。该行表示，随着中国老龄化进程的加速，公司药品分销业务仍将稳健发展。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/Y2EzOTlkNjExODQ0M2ZhODVjNjcxNDk5OTNhMDU4MjE2MzgxODI2NTQy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2EzOTlkNjExODQ0M2ZhODVjNjcxNDk5OTNhMDU4MjE2MzgxODI2NTQy.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949119","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099","00227"],"gpt_icon":0},{"id":"2489478254","title":"国药控股12月5日获南向资金加仓301.84万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489478254","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489478254?lang=zh_cn&edition=full","pubTime":"2024-12-06 09:30","pubTimestamp":1733448610,"startTime":"0","endTime":"0","summary":"12月5日, 南向资金增持国药控股301.84万股。截止当日收盘，港股通共持有国药控股31653.03万股，占流通股23.58%。国药控股近5个交易日上涨1.99%，港股通累计增持1355.20万股；近20个交易日上涨0.49%，港股通累计增持5402.80万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206093115a1d7cf53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206093115a1d7cf53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","BK1515","01099","LU1115378108.SGD","BK1197","LU0640798160.USD"],"gpt_icon":0},{"id":"2489043129","title":"中信证券资产管理有限公司增持国药控股(01099)161万股 每股作价约20.88港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489043129","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489043129?lang=zh_cn&edition=full","pubTime":"2024-12-05 19:02","pubTimestamp":1733396574,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，12月4日，中信证券资产管理有限公司增持国药控股(01099)161万股，每股作价20.8751港元，总金额约为3360.89万港元。增持后最新持股数目为9414.44万股，最新持股比例为7.02%。本交易涉及其他关联方：中信证券-云帆单一资产管理计划。补充资料：权益为中信证券资产管理有限公司代其管理的全部资产管理计划披露持有的国药控股股份有限公司 - H股权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221000.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","LU2289578879.USD","BK1258","BK1515","BK1521","BK0012","BK1516","BK1197","01099","06030","LU0405327494.USD","LU1064131003.USD","LU1997244956.HKD","LU1997245094.SGD","09983","BK0028","BK1542","BK1147","LU1064130708.USD","BK0183","BK0196","LU0405327148.USD","LU1115378108.SGD","LU1997245177.USD","LU2148510915.USD","600030","LU2495084118.USD","LU0640798160.USD","LU1794554557.SGD","BK1564","LU1328615791.USD","BK0276","BK0188","BK1229","LU1720050803.USD","BK1500"],"gpt_icon":0},{"id":"2489210405","title":"国药控股利润短期仍然承压，期待2025持续改善（繁体版）","url":"https://stock-news.laohu8.com/highlight/detail?id=2489210405","media":"第一上海","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489210405?lang=zh_cn&edition=full","pubTime":"2024-12-05 13:14","pubTimestamp":1733375640,"startTime":"0","endTime":"0","summary":"Q3收入恢复增长，利润仍然承压：公司2024年前三季度累计实现收入4424.2亿元，同比减少0.78%。公司Q3收入同比恢复增长1.88%，但主要是由于2023Q3医疗反腐导致的低基数，环比增速仅0.16%。归母净利润15.75亿元，同比减少20.94%，主要由于整体毛利率下降以及应收账款相关信用减值损失，以及23H1子公司收到大额拆迁补偿款所致。通过关闭亏损门店等多项措施，Q3国大药房亏损缩窄至0.25亿元。期待在有效举措下，零售业务能够在Q4持续改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205133046a1d577e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205133046a1d577e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01099","BK1515","BK1500","LU1115378108.SGD","LU0640798160.USD","BK1197"],"gpt_icon":0},{"id":"2489171361","title":"国药控股12月4日获南向资金加仓257.32万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489171361","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489171361?lang=zh_cn&edition=full","pubTime":"2024-12-05 09:30","pubTimestamp":1733362211,"startTime":"0","endTime":"0","summary":"12月4日, 南向资金增持国药控股257.32万股。截止当日收盘，港股通共持有国药控股31351.19万股，占流通股23.36%。国药控股近5个交易日上涨0.96%，港股通累计增持1146.04万股；近20个交易日上涨5.28%，港股通累计增持5303.68万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205093109a1d4f8e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205093109a1d4f8e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","LU0640798160.USD","BK1500","01099","BK1197","BK1515"],"gpt_icon":0},{"id":"2488999060","title":"【券商聚焦】摩根士丹利：预计在政策和市场动态的支持下 医疗保健行业将逐步实现结构性复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2488999060","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488999060?lang=zh_cn&edition=full","pubTime":"2024-12-03 17:38","pubTimestamp":1733218694,"startTime":"0","endTime":"0","summary":"摩根士丹利认为，尽管国内定价和竞争可能需要一段时间才能触底反弹，但那些具有海外业务曝光度的公司在充满挑战的一年中实现了超出预期的增长。总的来说，摩根士丹利对中国医疗保健行业的未来持谨慎乐观态度，预计在政策和市场动态的支持下，行业将逐步实现结构性复苏。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/YjEwODMyZjRkNWI4NjVjNzFhNGY4NWE0ZDExNzMxMDU0NzE5MDIz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjEwODMyZjRkNWI4NjVjNzFhNGY4NWE0ZDExNzMxMDU0NzE5MDIz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1948891","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0971096721.USD","LU1548497426.USD","IE00BZ1G4Q59.USD","LU0225283273.USD","LU0106261372.USD","01099","BK4581","LU1115378108.SGD","BK1500","LU0267386448.USD","LU0158827948.USD","LU0106831901.USD","LU0320765646.SGD","LU2023251221.USD","LU1720051017.SGD","MS","LU1720051108.HKD","LU2089284900.SGD","LU2271345857.HKD","LU1989772840.SGD","02607","BK4127","LU0640798160.USD","LU1074936037.SGD","LU0158827781.USD","LU1162221912.USD","LU1363072403.SGD","BK4516","LU0314104364.USD","LU1668664300.SGD","LU2028103732.USD","BK1515","IE00BKVL7J92.USD","LU2111349929.HKD","BK4504","BK4534","BK4588","LU0098860793.USD","LU1989772923.USD","LU2089283258.USD","BK4585","LU2357305700.SGD","BK1197","LU0006306889.USD"],"gpt_icon":0},{"id":"2488936478","title":"国药控股12月2日获南向资金加仓255.72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488936478","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488936478?lang=zh_cn&edition=full","pubTime":"2024-12-03 09:30","pubTimestamp":1733189409,"startTime":"0","endTime":"0","summary":"12月2日, 南向资金增持国药控股255.72万股。截止当日收盘，港股通共持有国药控股30691.35万股，占流通股22.86%。国药控股近5个交易日下跌0.24%，港股通累计增持1364.60万股；近20个交易日上涨4.74%，港股通累计增持5064.80万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203093104a267df0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203093104a267df0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","LU0640798160.USD","01099","LU1115378108.SGD","BK1197","BK1515"],"gpt_icon":0},{"id":"2487358735","title":"国药控股11月29日主力资金流入28万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2487358735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487358735?lang=zh_cn&edition=full","pubTime":"2024-11-29 16:15","pubTimestamp":1732868117,"startTime":"0","endTime":"0","summary":"11月29日, 国药控股股价涨1.00%，报收20.30元，成交金额2.17亿元，换手率0.79%，振幅2.49%，量比1.09。国药控股今日主力资金净流入28万元，连续3日净流入，上一交易日主力净流入227万元，今日环比减少87.67%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为38.89%，平均涨幅为1.25%。该股近5个交易日下跌0.25%，主力资金累计净流入664万元；近20日主力资金累计净流入1.65亿元，其中净流入天数为17日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129161535abe81494&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129161535abe81494&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0640798160.USD","01099","BK1515","LU1115378108.SGD","BK1197","BK1500"],"gpt_icon":0},{"id":"2486606833","title":"国药控股等在辽宁成立新公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2486606833","media":"中国能源网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486606833?lang=zh_cn&edition=full","pubTime":"2024-11-28 16:56","pubTimestamp":1732784160,"startTime":"0","endTime":"0","summary":"天眼查App显示，近日，国药控股（阜新）有限公司成立，法定代表人为李靖雷，注册资本1000万人民币，经营范围含药品批发、第三类医疗器械经营、保健食品（预包装）销售、第一类医疗器械销售、第二类医疗器械销售等。天眼查App显示，近日，国药控股（阜新）有限公司成立，法定代表人为李靖雷，注册资本1000万人民币，经营范围含药品批发、第三类医疗器械经营、保健食品（预包装）销售、第一类医疗器械销售、第二类医疗器械销售等。股东信息显示，该公司由国药控股（HK.01099）旗下国药控股沈阳有限公司、阜新国有资本投资管理集团有限公司共同持股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128165810abe56b7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128165810abe56b7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","BK1515","LU1115378108.SGD","BK1197","LU0640798160.USD","01099"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":0.0236},{"period":"1month","weight":0.0508},{"period":"3month","weight":0.2675},{"period":"6month","weight":-0.0091},{"period":"1year","weight":0.2182},{"period":"ytd","weight":0.1092}],"compareEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.1018},{"period":"1year","weight":0.2035},{"period":"ytd","weight":0.1653}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"国药控股股份有限公司是一家主要从事药品及医疗器械分销业务的中国公司。该公司通过四个部门运营业务。医药分销部门向医院、其他分销商、零售药店及诊所等客户分销医药制品。医疗器械业务部门向客户分销医疗器械，并提供安装和维修服务。医药零售业务部门经营医药连锁店。其他业务部门分销实验室用品、制造及分销化学试剂、生产及销售医药制品。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.002673},{"month":2,"riseRate":0.6,"avgChangeRate":0.035653},{"month":3,"riseRate":0.533333,"avgChangeRate":0.016153},{"month":4,"riseRate":0.4,"avgChangeRate":0.023272},{"month":5,"riseRate":0.6,"avgChangeRate":-0.007238},{"month":6,"riseRate":0.4,"avgChangeRate":-0.006667},{"month":7,"riseRate":0.466667,"avgChangeRate":-0.01785},{"month":8,"riseRate":0.466667,"avgChangeRate":0.013598},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.010762},{"month":10,"riseRate":0.625,"avgChangeRate":0.041428},{"month":11,"riseRate":0.4375,"avgChangeRate":-0.009899},{"month":12,"riseRate":0.5625,"avgChangeRate":-0.001278}],"exchange":"SEHK","name":"国药控股","nameEN":"SINOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药控股,01099,国药控股股票,国药控股股票老虎,国药控股股票老虎国际,国药控股行情,国药控股股票行情,国药控股股价,国药控股股市,国药控股股票价格,国药控股股票交易,国药控股股票购买,国药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}